Skip to main content
Watch Insiders
HALOHealthcare

Halozyme Therapeutics Inc. (HALO) Insider Trading

In the last 90 days, 3 Halozyme Therapeutics Inc. (HALO) insiders reported no open-market purchases and 6 sales totaling $22,104,197. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 8, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 8, 2026Helen TorleyPRESIDENT AND CEOSale60,000$110.18$6,610,500
Oct 1, 2026Matthew L. PosardCorporate insiderSale5,230$108.54$567,661
Sep 16, 2026Matthew L. PosardCorporate insiderSale18,996$107.74$2,046,582
Sep 11, 2026Helen TorleyPRESIDENT AND CEOSale60,000$107.28$6,436,710
Aug 19, 2026Helen TorleyPRESIDENT AND CEOSale60,000$104.59$6,275,592
Aug 10, 2026Bernadette ConnaughtonCorporate insiderSale1,626$102.80$167,153
Jul 8, 2026Helen TorleyPRESIDENT AND CEOSale1,923$79.77$153,391
Jul 1, 2026Bernadette ConnaughtonCorporate insiderSale1,625$76.71$124,651
Jun 29, 2026Mahesh KrishnanCorporate insiderSale7,304$75.00$547,800
Jun 3, 2026Helen TorleyPRESIDENT AND CEOSale50,000$67.40$3,370,010
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

HALO insider trading FAQ

Are HALO insiders buying or selling?
Over the last 90 days, HALO insiders were net sellers, reporting $0.00 of open-market purchases and $22,104,197 of sales.
When was the last HALO insider purchase?
No open-market insider purchase of Halozyme Therapeutics Inc. stock was reported in the last 90 days.
Where does HALO insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Halozyme Therapeutics Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.